Medtronic Launches InPen Integrated with CGM Data for People with Diabetes on MDI

 Medtronic Launches InPen Integrated with CGM Data for People with Diabetes on MDI

Medtronic Launches InPen Integrated with CGM Data for People with Diabetes on MDI

Shots:

  • The integration of real-time CGM data into the smart insulin pen app follows the acquisition of Companion Medical’s InPen to the Medtronic portfolio, as of Sept’2020
  • The integrated system provides real-time glucose readings alongside insulin dose information giving users everything they need to manage their diabetes through a single smartphone app
  • InPen is the first and only FDA-cleared smart2 insulin pen on the market for people on MDI. The InPen app will continue to display information from other compatible CGM systems on a three-hour delay

Click here­ to­ read the full press release/ article | Ref: Medtronic | Image: Medical Product Outsourcing

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post